- Home
- SMSI vs LGVN Comparison
SMSI vs LGVN Comparison
Compare SMSI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- LGVN
- Stock Information
- Founded
- SMSI 1982
- LGVN 2014
- Country
- SMSI United States
- LGVN United States
- Employees
- SMSI N/A
- LGVN N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SMSI Technology
- LGVN Health Care
- Exchange
- SMSI Nasdaq
- LGVN Nasdaq
- Market Cap
- SMSI 14.3M
- LGVN 16.6M
- IPO Year
- SMSI 1995
- LGVN 2021
- Fundamental
- Price
- SMSI $0.73
- LGVN $0.75
- Analyst Decision
- SMSI Strong Buy
- LGVN Strong Buy
- Analyst Count
- SMSI 1
- LGVN 2
- Target Price
- SMSI $5.00
- LGVN $6.50
- AVG Volume (30 Days)
- SMSI 145.0K
- LGVN 2.0M
- Earning Date
- SMSI 08-06-2025
- LGVN 08-13-2025
- Dividend Yield
- SMSI N/A
- LGVN N/A
- EPS Growth
- SMSI N/A
- LGVN N/A
- EPS
- SMSI N/A
- LGVN N/A
- Revenue
- SMSI $18,658,000.00
- LGVN $2,073,000.00
- Revenue This Year
- SMSI $0.03
- LGVN N/A
- Revenue Next Year
- SMSI $52.29
- LGVN $10.78
- P/E Ratio
- SMSI N/A
- LGVN N/A
- Revenue Growth
- SMSI N/A
- LGVN 68.67
- 52 Week Low
- SMSI $0.52
- LGVN $0.63
- 52 Week High
- SMSI $1.95
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- SMSI 49.22
- LGVN 32.11
- Support Level
- SMSI $0.71
- LGVN $0.80
- Resistance Level
- SMSI $0.77
- LGVN $0.87
- Average True Range (ATR)
- SMSI 0.04
- LGVN 0.05
- MACD
- SMSI 0.01
- LGVN 0.02
- Stochastic Oscillator
- SMSI 66.58
- LGVN 16.79
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.